Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Novartis AG CAD Hedged CIBC CDR (NVS) vs. Competitors

2 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
TSE:NVSNovartis AG CAD Hedged CIBC CDRCAD 30.28CAD 396.01B29.0224.25%―Unlock the TSE:NVS analyst price target with TipRanks PremiumTSE:NVSUnlock the TSE:NVS top-analyst price target with TipRanks Premium
TSE:BHCBausch Health CompaniesCAD 12.30CAD 4.60B-3.7744.71%HoldUnlock the TSE:BHC analyst price target with TipRanks PremiumTSE:NVS vs TSE:BHCUnlock the TSE:BHC top-analyst price target with TipRanks Premium
TSE:ROGRoche Holding Ltd CAD Hedged CIBC CDRCAD 31.80CAD 541.05B25.9929.32%―Unlock the TSE:ROG analyst price target with TipRanks PremiumTSE:NVS vs TSE:ROGUnlock the TSE:ROG top-analyst price target with TipRanks Premium

Performance Comparison

-40%-20%0%20%40%60%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
TSE:NVSNovartis AG CAD Hedged CIBC CDR30.286.6127.93%
TSE:BHCBausch Health Companies12.303.8545.56%
TSE:ROGRoche Holding Ltd CAD Hedged CIBC CDR31.807.9733.45%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts